Skip to content
6th World Congress on Targeting Phage Therapy 2023 - June 1-2, 2023 - Paris, France
  • Home
  • Welcome note
  • Agenda at a Glance
  • Faculty
  • Registration
  • Abstract Submission
  • Tracks
  • Venue
  • Previous Congresses
  • Contact
  • About TID
    • Aims

Category: Press Release

Targeting Phage Therapy 2023 final agenda, chairpersons, and speakers are released: 51+ communication, 125+ attendees, 30+ industrials

Posted on April 25, 2023May 9, 2023 by Targeting Phage Therapy
Posted in Press Release

Paris will host the 6th World Congress on Targeting Phage Therapy 2023 next June with more than 51 scientific communications from 27 different countries

Posted on April 11, 2023May 9, 2023 by Targeting Phage Therapy
Posted in Press Release

Targeting Phage Therapy 2023: Many questions remain to be answered!

Posted on January 26, 2023May 9, 2023 by Targeting Phage Therapy
Posted in Press Release

Targeting Phage Therapy 2023: Where are we today and what’s next?

Posted on January 5, 2023May 9, 2023 by Targeting Phage Therapy
Posted in Press Release

Targeting Phage Therapy News

  • Targeting Phage Therapy 2023 List of Posters
  • PHAGE Therapy, Applications, and Research Journal is a contributing partner
  • BiomX will share their latest data at Targeting Phage Therapy 2023
  • 70+ communications, 150+ attendees, 25+ industrials will be gathered
  • Cellexus will present their latest research during Targeting Phage Therapy 2023

Read more...

Scientific News

  • Microbiome-friendly phages join the campaign for better antimicrobials
  • Detection of Salmonella Typhi bacteriophages in surface waters as a scalable approach to environmental surveillance
  • Environmental Bacteriophages for Typhoid Surveillance and Evaluating Vaccine Impact
  • AP-PA02 Phage cocktail safely lowers P. aeruginosa load in Cystic Fibrosis trial
  • Compassionate Use of Phages Against Drug-Resistant Mycobacterial Disease
  • Tail-Engineered Phage P2 for Antimicrobials Delivery
  • Potential for Bacteriophages as Anticancer Agents
  • Managing phage therapy to help save lives
  • Phage trial to treat CF patients with multi-drug resistant bacterial infections
  • NIH-supported clinical trial of phage therapy for cystic fibrosis begins

Newsletters & Press Release

Newsletter Archives

Press Release

  • Sign up for Newsletter

Sponsors

BiomX

Media Partners



Targeting Phage Therapy is a Contributing Partner of PHAGE

Upcoming Events

Upcoming Events

Oct 17
October 17 - October 19

Targeting Microbiota 2023 Congress

View Calendar
  • Scientific News

    • Microbiome-friendly phages join the campaign for better antimicrobials
    • Detection of Salmonella Typhi bacteriophages in surface waters as a scalable approach to environmental surveillance
    • Environmental Bacteriophages for Typhoid Surveillance and Evaluating Vaccine Impact
    • AP-PA02 Phage cocktail safely lowers P. aeruginosa load in Cystic Fibrosis trial
    • Compassionate Use of Phages Against Drug-Resistant Mycobacterial Disease
    • Tail-Engineered Phage P2 for Antimicrobials Delivery
    • Potential for Bacteriophages as Anticancer Agents
    • Managing phage therapy to help save lives
    • Phage trial to treat CF patients with multi-drug resistant bacterial infections
    • NIH-supported clinical trial of phage therapy for cystic fibrosis begins
    • A novel virulent Litunavirus phage against multidrug resistant Pseudomonas aeruginosa
    • Anti-Biofilm Effect of Bacteriophages & Antibiotics against Uropathogenic E. coli
    Read More
Theme: Vogue by Kaira
Copyright © 2023 - Targeting Phage Therapy
  • Welcome note
  • Registration
  • Agenda at a glance
  • Abstract Submission
  • Tracks
  • Faculty
  • Previous Congresses
  • Scientific News
  • Legal Mentions & Privacy Policy
  • General Conditions of Sales
  • Contact